DDR2 ameliorates nonalcoholic hepatic steatosis by activating the AMPK/ACC pathway
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD), also termed non-alcoholic fatty liver disease (NAFLD), represents the predominant chronic hepatic condition globally, yet remains without successful drug-based interventions. Understanding the molecular mechanisms driving MAS...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Portfolio
2026-03-01
|
| Serier: | Scientific Reports |
| Fag: | |
| Online adgang: | https://doi.org/10.1038/s41598-026-42992-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
